Image

    Convergent Validation of Pharmacoeconomic Aspects of Benign Prostatic Hyperplasia Therapy in Montenegro

    Vera Dabanović
    Studysummary This study found that dutasteride is more cost-effective compared to finasteride for treating benign prostatic hyperplasia in Montenegro, justifying its funding by the national health insurance fund.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on fedorakg.kg.ac.rs →
    Discuss this study in the Community →